skip to main content
Idioma:
Refinado por: Nome da Publicação: Arthritis And Rheumatism remover assunto: Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol
Material Type:
Artigo 		Adicionar ao Meu Espaço

Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol

Stamp, Lisa K. ; Taylor, William J. ; Jones, Peter B. ; Dockerty, Jo L. ; Drake, Jill ; Frampton, Christopher ; Dalbeth, Nicola

Arthritis and rheumatism, 2012-08, Vol.64 (8), p.2529-2536

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
2
Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment
Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment

Stamp, Lisa K. ; O'Donnell, John L. ; Zhang, Mei ; James, Jill ; Frampton, Christopher ; Barclay, Murray L. ; Chapman, Peter T.

Arthritis and rheumatism, 2011-02, Vol.63 (2), p.412-421

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
3
Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long‐term methotrexate treatment
Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long‐term methotrexate treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long‐term methotrexate treatment

Stamp, Lisa K. ; O'Donnell, John L. ; Chapman, Peter T. ; Zhang, Mei ; Frampton, Christopher ; James, Jill ; Barclay, Murray L.

Arthritis and rheumatism, 2009-08, Vol.60 (8), p.2248-2256

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
4
Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long‐term methotrexate therapy
Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long‐term methotrexate therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long‐term methotrexate therapy

Stamp, Lisa K. ; O'Donnell, John L. ; Chapman, Peter T. ; Zhang, Mei ; James, Jill ; Frampton, Christopher ; Barclay, Murray L.

Arthritis and rheumatism, 2010-02, Vol.62 (2), p.359-368

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.